Randomized Trials of Cancer Drugs Are For Yesterday
RCTs are expensive, slow and yield frustratingly limited information. (Nature Outlook)
Randomized Trials of Cancer Drugs Are For Yesterday Read More »
medical topics
High-Quality Mammography: A Step Forward for Women’s Health
As a society, we can’t treat our way out of breast cancer.
It would be far too expensive. Although surgery, radiation, and
medical therapies for breast cancer have improved, the physical toxicity—and expense—of treating advanced-stage cancers would be too great.
High-Quality Mammography: A Step Forward for Women’s Health Read More »
A Call For More Research On Cancer’s Environmental Triggers
No question about cancer is more contentious than its causes.
A Call For More Research On Cancer’s Environmental Triggers Read More »
Commentary: How Patients Have Transformed A Medical Meeting About Breast Cancer
By speaking up, advocates at the meeting have shifted the direction of breast cancer research. Some are alive, improbably, as
Commentary: How Patients Have Transformed A Medical Meeting About Breast Cancer Read More »
Actually, Many New Cancer Drugs May Be Helpful And Worth Trying
Perhaps the literature fails to capture the clinical value of oncology drugs. This could happen for several reasons.
Actually, Many New Cancer Drugs May Be Helpful And Worth Trying Read More »
We Need To Tame The Price Of New Cancer Drugs
Are unbridled profits necessary to drive medical innovation and progress?
We Need To Tame The Price Of New Cancer Drugs Read More »